Topic

Articles

COVID-19 forces life sciences industry to make long overdue changes.

5 Ways DCTs Can Positively Impact Trial Diversity

Pandemic-forced move to remote monitoring calls for industry-wide collaboration.

Maximizing the Value of Remote Monitoring

Upcoming Clinical Trials Day allows industry to look back—and forward.

Clinical Trials Day Every May, or Every Day?

How asking better questions and leveraging site databases can expand access to more patients.

Revamping Site Feasibility as Trials Become Decentralized

Analysis of 330,000 clinical trials calls for improved protocol design process.

Modal Value Guided Clinical Trial Design Effectively Reduces Protocol Amendments

Operational and patient burden considerations for self-collection of blood specimens in clinical trials

Self-collection of Blood Specimens in Clinical Trials

A look forward to 2021 for the clinical trials industry.

2021 Promises for Clinical Trials

EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.

Industry Forced to Rethink Patient Participation in Trials

Regulatory concerns remain despite industry's quick adaptation of decentralized trials.

Decentralized Trials, Pros and Cons

The industry wide shift to decentralized clinical trials includes considerations for sponsors and CROs such as global availability, global technology, and data integration. 